High-frequency miniprobe endoscopic ultrasonography in the management of benign esophageal strictures

高频微型探头内镜超声在良性食管狭窄诊治中的应用

阅读:1

Abstract

BACKGROUND: Endoscopic ultrasonography (EUS) can predict the response to endoscopic dilatation by delineating the extent of esophageal wall involvement in benign strictures. In contrast to conventional echoendoscopes, the EUS miniprobe can be negotiated across the stricture and thus provide more information. This study retrospectively evaluated the role of miniprobe EUS in predicting the response to endoscopic dilatation in benign esophageal strictures. METHODS: We analyzed the records of 24 patients (mean age: 48.1±17.9 years) with benign esophageal strictures (corrosive 11, peptic 5, post-radiation 3, anastomotic 2, and others 3) who underwent miniprobe EUS prior to endoscopic dilatation. RESULTS: The stricture was located in the upper, middle and lower esophagus in 2, 9 and 13 patients, respectively. The mean length of the stricture was 3.4±1.9 cm. Miniprobe EUS was able to examine the stricture completely in all patients. The mucosa was involved in 6, mucosa and submucosa in 4, and mucosa, submucosa and muscularis propria in 14 patients. The mean maximum wall thickness of esophageal wall on EUS at the level of the stricture was 8.2±2.8 mm. The mean number of sessions required to achieve adequate dilation was 4.7±2.6. Patients with mucosal involvement required significantly fewer endoscopic sessions for adequate dilatation as compared to patients with muscularis propria involvement (1.8 vs. 6.2 sessions, respectively; P=0.0002). Patients with greater esophageal wall thickness required more endoscopic sessions (r=0.737) (P=0.00004). CONCLUSION: Miniprobe EUS, by delineating the extent of wall involvement as well as measuring wall thickness in benign esophageal strictures, can predict the response to endoscopic dilatation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。